Plain-English translation of NCT06769607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new auto-adjusting algorithm for positive airway pressure devices, which are machines that help people with obstructive sleep apnea breathe more easily during sleep. The study will compare how well this new algorithm works compared to the established algorithm that's currently available. You would use the device at home for up to 4 weeks with each algorithm to help researchers understand which one works better and which one feels better to use.
Sleep apnea devices can be uncomfortable or difficult for some people to adjust to, and doctors are always looking for ways to make them work better with fewer adjustments needed. This new algorithm was designed to automatically fine-tune the pressure levels more smoothly, and researchers want to confirm it actually helps people sleep better and feel more comfortable.
You likely qualify if…
You likely don't qualify if…
You would visit a study site to sign consent forms and get set up with the study device. Then you would take the device home and use it for up to 4 weeks with one algorithm, followed by another 4-week period using the other algorithm—each time replacing your own device. During this time, you may be asked to wear a commercial activity tracker to monitor your sleep and activity. You would complete questionnaires about your experience with each algorithm, and researchers would collect data from the device to compare how well each one works for you.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Australia
Sponsor
ResMed
Enrollment target
~80 participants
Started
April 2025
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sumudu Herath
ResMed
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.